BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

592 related articles for article (PubMed ID: 26522724)

  • 1. Endothelin A receptor drives invadopodia function and cell motility through the β-arrestin/PDZ-RhoGEF pathway in ovarian carcinoma.
    Semprucci E; Tocci P; Cianfrocca R; Sestito R; Caprara V; Veglione M; Castro VD; Spadaro F; Ferrandina G; Bagnato A; Rosanò L
    Oncogene; 2016 Jun; 35(26):3432-42. PubMed ID: 26522724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelin-1 drives invadopodia and interaction with mesothelial cells through ILK.
    Masi I; Caprara V; Spadaro F; Chellini L; Sestito R; Zancla A; Rainer A; Bagnato A; Rosanò L
    Cell Rep; 2021 Mar; 34(9):108800. PubMed ID: 33657382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of extracellular matrix degradation and metastatic spread by IQGAP1 through endothelin-1 receptor signalling in ovarian cancer.
    Chellini L; Caprara V; Spadaro F; Sestito R; Bagnato A; Rosanò L
    Matrix Biol; 2019 Aug; 81():17-33. PubMed ID: 30367951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelin-1 receptor drives invadopodia: Exploiting how β-arrestin-1 guides the way.
    Bagnato A; Rosanò L
    Small GTPases; 2018 Sep; 9(5):394-398. PubMed ID: 27690729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. hMENA is a key regulator in endothelin-1/β-arrestin1-induced invadopodial function and metastatic process.
    Di Modugno F; Caprara V; Chellini L; Tocci P; Spadaro F; Ferrandina G; Sacconi A; Blandino G; Nisticò P; Bagnato A; Rosanò L
    Proc Natl Acad Sci U S A; 2018 Mar; 115(12):3132-3137. PubMed ID: 29439204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-Arrestin 1 is required for endothelin-1-induced NF-κB activation in ovarian cancer cells.
    Cianfrocca R; Tocci P; Semprucci E; Spinella F; Di Castro V; Bagnato A; Rosanò L
    Life Sci; 2014 Nov; 118(2):179-84. PubMed ID: 24530737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelin-1/endothelin A receptor axis activates RhoA GTPase in epithelial ovarian cancer.
    Tocci P; Caprara V; Cianfrocca R; Sestito R; Di Castro V; Bagnato A; Rosanò L
    Life Sci; 2016 Aug; 159():49-54. PubMed ID: 26776837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β-arrestin-1 is a nuclear transcriptional regulator of endothelin-1-induced β-catenin signaling.
    Rosanò L; Cianfrocca R; Tocci P; Spinella F; Di Castro V; Spadaro F; Salvati E; Biroccio AM; Natali PG; Bagnato A
    Oncogene; 2013 Oct; 32(42):5066-77. PubMed ID: 23208497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelin A receptor/β-arrestin signaling to the Wnt pathway renders ovarian cancer cells resistant to chemotherapy.
    Rosanò L; Cianfrocca R; Tocci P; Spinella F; Di Castro V; Caprara V; Semprucci E; Ferrandina G; Natali PG; Bagnato A
    Cancer Res; 2014 Dec; 74(24):7453-64. PubMed ID: 25377471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel spatiotemporal RhoC activation pathway locally regulates cofilin activity at invadopodia.
    Bravo-Cordero JJ; Oser M; Chen X; Eddy R; Hodgson L; Condeelis J
    Curr Biol; 2011 Apr; 21(8):635-44. PubMed ID: 21474314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formin-like2 regulates Rho/ROCK pathway to promote actin assembly and cell invasion of colorectal cancer.
    Zeng Y; Xie H; Qiao Y; Wang J; Zhu X; He G; Li Y; Ren X; Wang F; Liang L; Ding Y
    Cancer Sci; 2015 Oct; 106(10):1385-93. PubMed ID: 26258642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KISS1R signaling promotes invadopodia formation in human breast cancer cell via β-arrestin2/ERK.
    Goertzen CG; Dragan M; Turley E; Babwah AV; Bhattacharya M
    Cell Signal; 2016 Mar; 28(3):165-176. PubMed ID: 26721186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β-arrestin1/YAP/mutant p53 complexes orchestrate the endothelin A receptor signaling in high-grade serous ovarian cancer.
    Tocci P; Cianfrocca R; Di Castro V; Rosanò L; Sacconi A; Donzelli S; Bonfiglio S; Bucci G; Vizza E; Ferrandina G; Scambia G; Tonon G; Blandino G; Bagnato A
    Nat Commun; 2019 Jul; 10(1):3196. PubMed ID: 31324767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelin-1/endothelin A receptor-mediated biased signaling is a new player in modulating human ovarian cancer cell tumorigenesis.
    Teoh JP; Park KM; Wang Y; Hu Q; Kim S; Wu G; Huang S; Maihle N; Kim IM
    Cell Signal; 2014 Dec; 26(12):2885-95. PubMed ID: 25194819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear β-arrestin1 is a critical cofactor of hypoxia-inducible factor-1α signaling in endothelin-1-induced ovarian tumor progression.
    Cianfrocca R; Tocci P; Rosanò L; Caprara V; Sestito R; Di Castro V; Bagnato A
    Oncotarget; 2016 Apr; 7(14):17790-804. PubMed ID: 26909598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differing contributions of LIMK and ROCK to TGFβ-induced transcription, motility and invasion.
    Morin P; Wickman G; Munro J; Inman GJ; Olson MF
    Eur J Cell Biol; 2011 Jan; 90(1):13-25. PubMed ID: 21074289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blocking endothelin-1-receptor/β-catenin circuit sensitizes to chemotherapy in colorectal cancer.
    Cianfrocca R; Rosanò L; Tocci P; Sestito R; Caprara V; Di Castro V; De Maria R; Bagnato A
    Cell Death Differ; 2017 Oct; 24(10):1811-1820. PubMed ID: 28708138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelin-1 promotes epithelial-to-mesenchymal transition in human ovarian cancer cells.
    Rosanò L; Spinella F; Di Castro V; Nicotra MR; Dedhar S; de Herreros AG; Natali PG; Bagnato A
    Cancer Res; 2005 Dec; 65(24):11649-57. PubMed ID: 16357176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-arrestin-1 mediates the endothelin-1-induced activation of Akt and integrin-linked kinase.
    Cianfrocca R; Rosanò L; Spinella F; Di Castro V; Natali PG; Bagnato A
    Can J Physiol Pharmacol; 2010 Aug; 88(8):796-801. PubMed ID: 20725137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein tyrosine phosphatase SHP2 promotes invadopodia formation through suppression of Rho signaling.
    Tsai WC; Chen CL; Chen HC
    Oncotarget; 2015 Sep; 6(27):23845-56. PubMed ID: 26204488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.